Immunology Breakfast Briefing 2025
Published on June 11, 2025.
Updated on February 03, 2026.
Briefing
Hosted
Topic
New Targeted Therapies: the Way Forward.
About
Targeted therapies (biological treatments, JAK inhibitors, etc.) in Immunology are booming, with a growing number of new molecules on the market and multiple extensions of indication.
It is against this backdrop that the APLUSA team is pleased to invite you to the second edition of the APLUSA Immunology Matinee, whose theme will be the management of ‘new’ indications in dermatology and pneumology: practices, innovations, prospects, challenges, etc.
This meeting between dermatologists and respirologists from hospitals and clinics, pharmaceutical industry professionals and APLUSA experts will address three main themes:
- What information on these new therapies have physicians received to date?
- How are doctors using them or planning to use them in patient care (challenges, practices)?
- What are their needs? What expectations do doctors have in terms of information and support?
Download Report
The report is available in French only.
